ArticleOncogene2025

Using prognostic signatures and machine learning to identify core features associated with response to CDK4/6 inhibitor-based therapy in metastatic breast cancer.

Agnieszka K Witkiewicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.